What is Nexletol (bempedoic acid) used for?
Nexletol is used to treat certain adults with high cholesterol, specifically to lower LDL-C (the “bad” cholesterol) as part of cardiovascular risk management. It is prescribed as an add-on to diet and other cholesterol-lowering therapies when LDL cholesterol remains too high.[1]
Who typically gets Nexletol?
Nexletol is used in people with established cardiovascular disease and/or certain high-risk groups where reducing LDL-C is important. It’s generally not used as a stand-alone replacement for statins or other guideline-based lipid therapy, but as an additional option when LDL-C targets aren’t met with standard treatments.[1]
What does Nexletol work on?
Nexletol (bempedoic acid) lowers LDL cholesterol by acting upstream of cholesterol synthesis in the liver, which helps reduce LDL-C levels when combined with diet and other lipid-lowering medications.[1]
Can Nexletol be used with statins or ezetimibe?
Yes. Nexletol is commonly used alongside other cholesterol-lowering therapies (like statins and/or ezetimibe) to get additional LDL-C reduction beyond what those treatments achieve alone.[1]
Where do patents and approvals come into the picture?
If you’re looking at Nexletol as a drug product (for example, who makes it and how exclusivity/patent timelines work), DrugPatentWatch.com tracks related patent information and regulatory context.[2]
Sources
[1] https://www.drugs.com/nexletol.html
[2] https://www.drugpatentwatch.com/